Cell cycle regulation of the c-Myc transcriptional activation domain

Molecular and Cellular Biology

Volumn 13, Issue 7, 1993, Pages 4125-4136

  Seth, Alpna ^a,b   Gupta, Shashi ^a   Davis, Roger J ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b HARVARD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CRICETINAE; CRICETULUS GRISEUS;

DNA BINDING PROTEIN; GENE PRODUCT;

AMINO ACID ANALYSIS; ANIMAL CELL; ARTICLE; BINDING SITE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE PHASE; CELL CYCLE S PHASE; CELL SYNCHRONIZATION; CHO CELL; DNA BINDING; ENZYME ACTIVITY; GENETIC TRANSCRIPTION; IMMUNOPRECIPITATION; NONHUMAN; ONCOGENE C MYC; PHOSPHORYLATION; POINT MUTATION; PRIORITY JOURNAL; TRANSACTIVATION;

ANIMAL; BASE SEQUENCE; BINDING SITES; CELL CYCLE; CELL LINE; CHO CELLS; DNA; GENE EXPRESSION REGULATION; GENES, MYC; HAMSTERS; KINETICS; MOLECULAR SEQUENCE DATA; PHOSPHORYLATION; SERINE; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION, GENETIC;

EID: 0027232220     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.13.7.4125     Document Type: Article

References (119)

1. Adams, R. L. P., and J. G. Lindsay. 1967. Hydroxyurea: reversal of inhibition and use as a cell-synchronizing agent. J. Biol. Chem. 242:1314-1317.
2. Alvarez, E., I. C. Northwood, F. A. Gonzalez, D. A. Latour, A. Seth, C. Abate, T. Curran, and R. J. Davis. 1991. Pro-Leu-Ser/Thr-Pro is a consensus primary sequence for substrate protein phosphorylation: characterization of the phosphorylation of c-myc and c-jun proteins by an epidermal growth factor receptor threonine 669 protein kinase. J. Biol. Chem. 266:15277-15285.
3. Amati, B., M. W. Brooks, N. Levy, T. D. Littlewood, G. I. Evan, and H. Land. 1993. Oncogenic activity of the c-Myc protein requires dimerization with Max. Cell 72:233-245.
4. Amati, B., S. Dalton, M. W. Brooks, T. D. Littlewood, G. I. Evan, and H. Land. 1992. Transcriptional activation by the human c-Myc oncoprotein in yeast requires interaction with Max. Nature (London) 359:423-426.
5. Amin, C., A. J. Wagner, and N. Hay. 1993. Sequence-specific transcriptional activation by Myc and repression by Max. Mol. Cell. Biol. 13:383-390.
6. Armelin, H. A., M. C. S. Armelin, K. Kelly, T. Stewart, P. Leder, B. H. Cochran, and C. D. Stiles. 1984. Functional role for c-myc in mitogenic response to platelet derived growth factor. Nature (London) 310:655-660.
7. Ayer, D. E., L. Kretzner, and R. N. Eisenman. 1993. Mad: a heterodimeric partner for Max that antagonizes Myc transcriptional activity. Cell 72:211-222.
8. Bar-Ner, M., L. T. Messing, C. M. Cultraro, M. J. Birrer, and S. Segal. 1992. Regions within the c-Myc protein that are necessary for transformation are also required for inhibition of differentiation of murine erythroleukemia cells. Cell Growth Differ. 3:183-190.
9. Barrett, C. B., E. Erikson, and J. L. Maller. 1992. A purified S6 kinase kinase from Xenopus eggs activates S6 kinase II and autophosphorylates on serine, threonine, and tyrosine residues. J. Biol. Chem. 267:4408-4415.
10. Berberich, S. J., and M. D. Cole. 1992. Casein kinase II inhibits the DNA-binding activity of Max homodimers but not Myc/ Max heterodimers. Genes Dev. 6:166-176.
11. Birrer, M. J., L. Raveh, H. Dosaka, and S. Segal. 1989. A transfected L-myc gene can substitute for c-myc in blocking murine erythroleukemia differentiation. Mol. Cell. Biol. 9:2734-2737.
12. Bissonnette, R. P., F. Echeverri, A. Mahboubi, and D. R. Green. 1992. Apoptic cell death induced by c-myc is inhibited by bcl-2. Nature (London) 359:552-556.
13. Blackwell, T. K., L. Kretzner, E. M. Blackwood, R. N. Eisenman, and H. Weintraub. 1990. Sequence-specific DNA binding by the c-Myc protein. Science 250:1149-1151.
14. Blackwood, E. M., and R. N. Eisenman. 1991. Max: A helixloop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc. Science 251:1211-1217.
15. Blackwood, E. M., L. Kretzner, and R. N. Eisenman. 1992. Myc and Max function as a nucleoprotein complex. Curr. Opin. Genet. Dev. 2:227-235.
16. Blackwood, E. M., B. Lüscher, and R. N. Eisenman. 1992. Myc and Max associate in vivo. Genes Dev. 6:71-80.
17. Boulton, T. G., S. H. Nye, D. J. Robbins, N. Y. Ip, E. Radziejewska, S. D. Morgenbesser, R. A. DePinho, N. Panayotatos, M. H. Cobb, and G. D. Yancopoulos. 1991. ERKs: a family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF. Cell 68:663-675.
18. Boulton, T. G., G. D. Yancopoulos, J. S. Gregory, C. Slaughter, C. Moomaco, J. Hsu, and M. H. Cobb. 1990. An insulin stimulated protein kinase similar to yeast kinases involved in cell cycle control. Science 249:64-67.
19. mpk, the meiosis-activated myelin basic protein kinase. J. Biol. Chem. 266:15180-15184.
20. Cobb, M. H., T. G. Boulton, and D. J. Robbins. 1991. Extracellular signal-regulated kinases: ERKs in progress. Cell Regul. 2:965-978.
21. Coffey, R. J., Jr., C. C. Bascom, N. J. Sipes, R. Graves-Deal, B. E. Weissman, and H. L. Moses. 1988. Selective inhibition of growth-related gene expression in murine keratinocytes by transforming growth factor beta. Mol. Cell. Biol. 8:3088-3093.
22. Cole, M. D. 1986. The myc oncogene: its role in transformation and differentiation. Annu. Rev. Genet. 20:361-384.
23. Cole, M. D. 1991. Myc meets its Max. Cell 65:715-716.
24. Copolla, J. S., and M. D. Cole. 1986. Constitutive c-myc oncogene expression blocks mouse erythroleukemia cell differentiation but not commitment. Nature (London) 320:760-763.
25. Countaway, J. L., I. C. Northwood, and R. J. Davis. 1989. Mechanism of phosphorylation of the epidermal growth factor receptor at threonine 669. J. Biol. Chem. 264:10828-10835.
26. Coyle, M. B., and B. Strauss. 1970. Cell killing and the accumulation of breaks in the DNA of HEp-2 cells incubated in the presence of hydroxyurea. Cancer Res. 30:2314-2319.
27. Dalton, S. 1992. Cell cycle regulation of the human cdc2 gene. EMBO J. 11:1797-1804.
28. Dean, M., R. A. Levine, W. Ran, M. S. Kindy, G. E. Sonnenshein, and J. Campisi. 1986. Regulation of c-myc transcription and mRNA abundance by serum growth factors and cell contact. J. Biol. Chem. 261:9161-9166.
29. DeCaprio, J. A., J. W. Ludlow, D. Lynch, Y. Furukawa, J. Griffen, H. Piwnica-Worms, C.-H. Huang, and D. M. Livingston. 1989. The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory element. Cell 58:1085-1095.
30. Dmitrovsky, E., W. M. Kuehl, G. F. Hollis, I. R. Kirsch, T. P. Bender, and S. Segal. 1986. Expression of a transfected human c-myc oncogene inhibits differentiation of a mouse erythroleukaemia cell line. Nature (London) 322:748-750.
31. Dotto, G. P., M. Z. Gilman, M. Maruyama, and R. A. Weinberg. 1986. c-myc and c-fos expression in differentiating mouse primary keratinocytes. EMBO J. 5:2853-2857.
32. Downs, K. M., G. R. Martin, and J. M. Bishop. 1989. Contrasting patterns of myc and N-myc expression during gastrulation of the mouse embryo. Genes Dev. 3:860-869.
33. Dulic, V., E. Lees, and S. I. Reed. 1992. Association of human cyclin E with a periodic G1-S phase protein kinase. Science 257:1958-1961.
34. Eilers, M., D. Picard, K. R. Yamamoto, and J. M. Bishop. 1989. Chimaeras of myc oncoprotein and steroid receptors cause hormone-dependent transformation of cells. Nature (London) 340:66-68.
35. Eilers, M., S. Schrim, and J. M. Bishop. 1991. The Myc protein activates transcription of the α-prothymosin gene. EMBO J. 10:133-141.
36. Eisenman, R. N., C. Y. Tachibana, H. D. Abrams, and S. R. Hann. 1985. v-myc- and c-myc-encoded proteins are associated with the nuclear matrix. Mol. Cell. Biol. 5:114-126.
37. Evan, G. I., A. H. Wyllie, C. S. Gilbert, T. D. Littlewood, H. Land, M. Brooks, C. M. Waters, L. Z. Penn, and D. C. Hancock. 1992. Induction of apoptosis in fibroblasts by c-myc protein. Cell 69:119-128.
38. cdc2 and a MAP-kinase homolog in Xenopus oocytes and eggs. Mol. Cell. Biol. 11:1965-1971.
39. Freytag, S. O., C. V. Dang, and W. M. F. Lee. 1990. Definition of the activities and properties of c-myc required to inhibit cell differentiation. Cell Growth Differ. 1:339-343.
40. TCF by MAP kinase stimulates ternary complex formation at c-fos promoter. Nature (London) 358:414-417.
41. Gonzalez, F. A., D. L. Raden, and R. J. Davis. 1991. Identification of substrate recognition determinants for human ERK1 and ERK2 protein kinases. J. Biol. Chem. 266:22159-22163.
42. Goodrich, D. W., and W.-H. Lee. 1992. Abrogation by c-myc of G1 phase arrest induced by RB protein but not by p53. Nature (London) 360:177-179.
43. Gotoh, Y., K. Moriyama, S. Matsuda, E. Okamura, T. Kishimoto, H. Kawasaki, K. Suzuki, and E. Nishida. 1991. Xenopus M phase MAP kinase: isolation of its cDNA and activation by MPF. EMBO J. 10:2661-2668.
44. Gotoh, Y., E. Nishide, S. Matsuda, N. Shiina, H. Kosako, K. Shiokawa, T. Akiyama, K. Ohta, and H. Sakai. 1991. Purification and properties of an M-phase activated MAP kinase from Xenopus oocytes and its effects on microtubule dynamics in vitro. Nature (London) 349:251-254.
45. Gupta, S., A. Seth, and R. J. Davis. 1993. Transactivation of gene expression by Myc is inhibited by mutation at the phosphorylation sites Thr-58 and Ser-62. Proc. Natl. Acad. Sci. USA 90:3216-3220.
46. Gurley, L. R., R. A. Walters, and R. A. Tobey. 1975. Sequential phosphorylation of histone subfractions in the Chinese hamster cell cycle. J. Biol. Chem. 250:3936-3944.
47. Gutman, A., and B. Wasylyk. 1991. Nuclear targets for transcription regulation by oncogenes. Trends Genet. 7:49-54.
48. Halazonetis, T. D., and A. N. Kandil. 1991. Determination of the c-Myc DNA binding site. Proc. Natl. Acad. Sci. USA 88:6162-6166.
49. Hann, S. R., C. B. Thompson, and R. N. Eisenman. 1985. c-myc oncogene protein synthesis is independent of the cell cycle in human and avian cells. Nature (London) 314:366-369.
50. Heikkila, R., G. Schwab, E. Wickstrom, S. L. Loke, D. H. Pluznik, R. Watt, and L. M. Neckers. 1987. A c-myc antisense oligodeoxynucleotide inhibits entry into S phase but not progress from G0-G1. Nature (London) 328:445-449.
51. Holt, J. T., R. L. Redner, and A. W. Nienhuis. 1988. An oligomer complementary to c-myc mRNA inhibits proliferation of HL-60 promyelocytic cells and induces differentiation. Mol. Cell. Biol. 8:963-973.
52. Hourdry, J., A. Brulfert, M. Gusse, D. Schoevaert, M. V. Taylor, and M. Mechali. 1988. Localization of c-myc expression during oogenesis and embryonic development in Xenopus laevis. Development 104:631-641.
53. Hunter, T. 1991. Cooperation between oncogenes. Cell 64:249-270.
54. Hunter, T., and M. Karin. 1992. The regulation of transcription by phosphorylation. Cell 70:375-387.
55. Jackson, S. P. 1992. Regulating transcription factor activity by phosphorylation. Trends Cell. Biol. 2:104-108.
56. Jaffredo, T., B. Vandenbunder, and F. Dieterlen-Lievre. 1989. In situ study of c-Myc protein expression during avian development. Development 105:679-695.
57. Kaelin, W. G., Jr., D. C. Pallas, J. A. DeCaprio, F. J. Kaye, and D. M. Livingston. 1991. Identification of cellular proteins that can interact specifically with the T/E1A binding region of the retinoblastoma gene product. Cell 64:521-532.
58. Karn, J., J. V. Watson, A. D. Lowe, S. M. Green, and W. Vedeckis. 1989. Regulation of cell cycle duration by c-myc levels. Oncogene 4:773-787.
59. Kato, G. J., J. Barrett, M. Villa-Garcia, and C. V. Dang. 1990. An amino-terminal c-Myc domain required for neoplastic transformation activates transcription. Mol. Cell. Biol. 10: 5914-5920.
60. Kato, G. J., and C. V. Dang. 1992. Function of the c-Myc oncoprotein. FASEB J. 6:3065-3072.
61. Kato, G. J., W. M. F. Lee, L. Chen, and C. V. Dang. 1992. Max: functional domains and interaction with c-Myc. Genes Dev. 6:81-92.
62. Kelly, K., B. H. Cochran, C. D. Stiles, and P. Leder. 1983. Cell-specific regulation of the c-myc gene by lymphocyte mitogens and platelet-derived growth factor. Cell 35:603-610.
63. Kerkhoff, E., K. Bister, and K. H. Klempnauer. 1991. Sequence-specific DNA binding by Myc proteins. Proc. Natl. Acad. Sci. USA 88:4323-4327.
64. King, M. W., J. M. Roberts, and R. N. Eisenman. 1986. Expression of the c-myc proto-oncogene during development of Xenopus laevis. Mol. Cell. Biol. 6:4499-4508.
65. Kohl, N. E., and H. R. Ruley. 1987. Role of c-myc in the transformation of REF52 cells by viral and cellular oncogenes. Oncogene 2:41-48.
66. Kretzner, L., E. M. Blackwood, and R. N. Eisenman. 1992. Myc and Max proteins possess distinct transcriptional activities. Nature (London) 359:426-429.
67. Kume, T. U., S. Takada, and M. Obinata. 1988. Probability that the commitment of murine erythroleukemia cell differentiation is determined by the c-myc level. J. Mol. Biol. 202:779-786.
68. Langdon, W. Y., A. W. Harris, and S. Cory. 1988. Growth of Eμ-myc B-lymphoid cells in vitro and their evolution towards autonomy. Oncogene Res. 3:271-279.
69. 2 is phosphorylated and activated by MAP kinase. Cell 72:269-278.
70. Lüscher, B., and R. N. Eisenman. 1990. New light on Myc and Myb, part 1. Myc. Genes & Dev. 4:2025-2035.
71. Lüscher, B., and R. N. Eisenman. 1992. Mitosis-specific phosphorylation of the nuclear oncoproteins Myc and Myb. J. Cell Biol. 118:775-784.
72. Lüscher, B., E. A. Kuenzel, E. G. Krebs, and R. N. Eisenman. 1989. Myc oncoproteins are phosphorylated by casein kinase II. EMBO J. 8:1111-1119.
73. Mäkelä, T. P., P. J. Koskinen, I. Västrik, and K. Alitalo. 1992. Alternative forms of Max as enhancers or suppressors of Myc-Ras cotransformation. Science 256:373-377.
74. Marcu, K. B., S. A. Bossone, and A. J. Patel. 1992. myc function and regulation. Annu. Rev. Biochem. 61:809-860.
75. Maruyama, K. S., S. Schiavi, W. Huse, G. L. Johnson, and E. Ruley. 1987. myc and E1A oncogenes alter the responses of PC12 cells to nerve growth factor and block differentiation. Oncogene 1:361-367.
76. Mittnacht, S., and R. A. Weinberg. 1991. G1/S phosphorylation of the retinoblastoma protein is associated with an altered affinity for the nuclear compartment. Cell 65:381-393.
77. Norbury, C., and P. Nurse. 1992. Animal cell cycles and their control. Annu. Rev. Biochem. 61:441-470.
78. Northwood, I. C., F. A. Gonzalez, M. Wartmann, D. L. Raden, and R. J. Davis. 1991. Isolation and characterization of two growth factor-stimulated protein kinases that phosphorylate the epidermal growth factor receptor at threonine 669. J. Biol. Chem. 266:15266-15276.
79. Palmieri, S., P. Kahn, and T. Graf. 1983. Quail embryo fibroblasts transformed by four v-myc containing virus isolates show enhanced proliferation but are non-tumorigenic. EMBO J. 2:2385-2389.
80. Papoulas, O., N. G. Williams, and R. E. Kingston. 1992. DNA binding activities of c-Myc purified from eukaryotic cells. J. Biol. Chem. 267:10470-10480.
81. Pedrali-Noy, G., S. Soadari, A. Miller-Faures, A. O. A. Miller, J. Kruppa, and G. Koch. 1980. Synchronization of HeLa cell cultures by inhibition of DNA polymerase a with aphidicolin. Nucleic Acids Res. 8:377-387.
82. Penn, L. J. Z., E. M. Laufer, and H. Land. 1990. c-Myc: evidence for multiple regulatory functions. Semin. Cancer Biol. 1:69-87.
83. Pietenpol, J. A., K. Münger, P. M. Howley, R. W. Stein, and H. Moses. 1991. Factor-binding element in the human c-myc promoter involved in transcriptional regulation by transforming growth factor β1 and by the retinoblastoma gene product. Proc. Natl. Acad. Sci. USA 88:10227-10231.
84. Pietenpol, J. A., R. W. Stein, E. Moran, P. Yacluk, R. Schlegel, R. M. Lyons, M. R. Pittelkow, K. Munger, P. M. Howley, and H. Moses. 1990. TGF-β1 inhibition of c-myc transcription and growth in keratinocytes is abrogated by viral transforming proteins with pRB binding domains. Cell 61:777-785.
85. Pines, J., and T. Hunter. 1991. Human cyclins A and B1 are differentially located in the cell and undergo cell cycle-dependent nuclear transport. J. Cell. Biol. 115:1-17.
86. Posada, J., and J. A. Cooper. 1992. Requirements for phosphorylation of MAP kinase during meiosis in Xenopus oocytes. Science 255:212-215.
87. Posada, J., J. Sanghera, S. L. Pelech, R. Aefersold, and J. A. Cooper. 1991. Tyrosine phosphorylation and activation of homologous protein kinases during oocyte maturation and mitogenic activation of fibroblasts. Mol. Cell. Biol. 11:2517-2528.
88. Prendergast, G. C., R. Hopewell, B. J. Gorham, and E. B. Ziff. 1992. Biphasic effect of Max on Myc cotransformation activity and dependence on amino- and carboxy-terminal Max functions. Genes Dev. 6:2429-2439.
89. Prendergast, G. C., D. Lawe, and E. B. Ziff. 1991. Association of Myn, the murine homolog of Max, with c-Myc stimulates methylation-sensitive DNA binding and Ras co-transformation. Cell 65:395-407.
90. Prendergast, G. C., and E. B. Ziff. 1991. Methylation-sensitive sequence-specific DNA binding by the c-Myc basic region. Science 251:186-189.
91. Prendergast, G. C., and E. B. Ziff. 1992. A new bind for Myc. Trends Genet. 8:91-96.
92. Prochownik, E. V., and J. Kukowska. 1986. Deregulated expression of c-myc by murine erythroleukemia cells prevents differentiation. Nature (London) 322:848-850.
93. Pulverer, B. J., J. M. Kyriakis, J. Avruch, E. Nikolakaki, and J. R. Woodgett. 1991. Phosphorylation of c-Jun mediated by MAP kinases. Nature (London) 353:670-674.
94. Rabbitts, P. H., J. W. Watson, A. Lamond, A. Forster, M. A. Stinson, G. Evan, W. Fischer, E. Athertton, M. A. Sheppard, and T. H. Rabbitts. 1985. Metabolism of c-myc gene products: c-myc mRNA and protein expression in the cell cycle. EMBO J. 4:2009-2015.
95. Roussel, M. F., J. L. Cleveland, S. A. Shurtleff, and C. J. Sherr. 1991. Myc rescue of a mutant CSF-1 receptor impaired in mitogenic signalling. Nature (London) 353:361-363.
96. Rustgi, A. K., N. Dyson, and R. Bernards. 1991. Aminoterminal domains of c-Myc and N-Myc proteins mediate binding to the retinoblastoma gene product. Nature (London) 352:541-544.
97. Saksela, K., T. P. Mäkelä, K. Hughes, J. R. Woodgett, and K. Alitalo. 1992. Activation of protein kinase C increases phosphorylation of the L-myc trans-activator domain at a GSK-3 target site. Oncogene 7:347-352.
98. Sanghera, J., H. B. Paddon, and S. L. Pelech. 1991. Role of protein phosphorylation in the maturation-induced activation of a myelin basic protein kinase from sea star oocytes. J. Biol. Chem. 266:6700-6707.
99. 2-terminal domain of c-Myc increases transactivation of gene expression. J. Biol. Chem. 266:23521-23524.
100. Seth, A., F. A. Gonzalez, S. Gupta, D. L. Raden, and R. J. Davis. 1992. Signal transduction within the nucleus by mitogenactivated protein kinase. J. Biol. Chem. 267:24796-24804.
101. Shi, Y., J. M. Glynn, L. J. Guilbert, T. G. Cotter, R. P. Bissonnette, and D. R. Green. 1992. Role for c-myc in activation-induced apoptic cell death in T cell hybridomas. Science 257:212-214.
102. Shibuya, E. K., T. G. Boulton, M. H. Cobb, and J. V. Ruderman. 1992. Activation of p42 MAP kinase and the release of oocytes from cell cycle arrest. EMBO J. 11:3963-3975.
103. Shibuya, H., M. Yoneyama, J. Ninomiya-Tsuji, K. Matsumoto, and T. Taniguchi. 1992. IL-2 and EGF receptors stimulate the hematopoietic cell cycle via different signaling pathways: demonstration of a novel role for c-myc. Cell 70:57-67.
104. Sorrentino, V., M. D. Drozdoff, M. D. McKinney, L. Zeitz, and E. Fleissner. 1986. Potentiation of growth factor activity by exogeneous c-myc expression. Proc. Natl. Acad. Sci. USA 83:8167-8171.
105. Stern, D. F., A. B. Roberts, N. S. Roche, M. B. Sporn, and R. A. Weinberg. 1986. Differential responsiveness of myc- and ras-transfected cells to growth factors: selective stimulation of myc-transfected cells by epidermal growth factor. Mol. Cell. Biol. 6:870-877.
106. Stokoe, D., P. Campbell, S. Nakielny, H. Hidaka, S. J. Leevers, C. J. Marshall, and P. Cohen. 1992. MAPKAP kinase-2; a novel protein kinase activated by mitogen-activated protein kinase. EMBO J. 11:3985-3994.
107. Street, A. J., E. Blackwood, B, Lüscher, and R. N. Eisenman. 1990. Mutational analysis of the carboxy-terminal casein kinase II phosphorylation site in human c-Myc. Curr. Top. Microbiol. Immunol. 166:251-258.
108. Sturgill, T. W., L. B. Ray, E. Erikson, and J. L. Maller. 1988. Insulin-stimulated MAP-2 kinase phosphorylates and activates ribosomal protein S6 kinase II. Nature (London) 334:715-718.
109. Takishima, K., I. Griswold-Prenner, T. Ingebritsen, and M. R. Rosner. 1991. Epidermal growth factor (EGF) receptor T669 peptide kinase from 3T3-L1 cells is an EGF-stimulated "MAP" kinase. Proc. Natl. Acad. Sci. USA 88:2520-2524.
110. Tamemoto, H., T. Kadowaki, K. Tobe, K. Ueki, T. Izumi, Y. Chatani, M. Kohno, M. Kasuga, Y. Yazaki, and Y. Akanuma. 1992. Biphasic activation of two mitogen-activated protein kinases during the cell cycle in mammalian cells. J. Biol. Chem. 267:20293-20297.
111. Tate, E. H., M. E. Wilder, S. Cram, and W. Wharton. 1983. A method for staining 3T3 cell nuclei with propidium iodide in hypotonic solution. Cytometry 4:211-215.
112. Thompson, C. B., P. B. Challoner, P. E. Neiman, and M. Groudine. 1985. Levels of c-myc oncogene mRNA are invariant throughout the cell cycle. Nature (London) 314:363-366.
113. Tobey, R. A., N. Oishi, and H. A. Crissman. 1990. Cell cycle synchronization: reversible induction of G2 synchrony in cultured rodent and human diploid fibroblasts. Proc. Natl. Acad. Sci. USA 87:5104-5108.
114. Torres, R., N. Schreiber-Agus, S. D. Morgenbesser, and R. A. Depinho. 1992. Myc and Max: a putative transcriptional complex in search of a cellular target. Curr. Opin. Cell Biol. 4:468-474.
115. Waitz, W., and P. Loidl. 1991. Cell cycle dependent association of c-Myc protein with the nuclear matrix. Oncogene 6:29-35.
116. Waters, C. M., T. D. Littlewood, D. C. Hancock, J. P. Moore, and G. I. Evan. 1991. c-Myc protein expression in untransformed fibroblasts. Oncogene 6:797-805.
117. Weinberg, R. A. 1991. Tumor suppressor genes. Science 254:1138-1146.
118. Woodford, T. A., and A. B. Pardee. 1986. Histone H1 kinase in exponential and synchronous populations of chinese hamster fibroblasts. J. Biol. Chem. 261:4669-4676.
119. Zervos, A. S., J. Gyüris, and R. Brent. 1993. Mxil, a protein that specifically interacts with Max to bind Myc-Max recognition sites. Cell 72:223-232.